P3 Health Partners Inc. income statement
In fiscal 2025, P3 Health Partners Inc. reported revenue of $1.46bn, down 2.8% on the year before, operating income of −$270m (a -18.5% margin) and net income of −$148m, or −$45.26 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.
Income statement
| Fiscal year | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMJun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 145 | 491 | 579 | 1,049 | 1,266 | 1,500 | 1,459 | 1,503 |
| Selling and marketing | 1 | 2 | 2 | 5 | 3 | 1 | 1 | — |
| General and administrative | 36 | 53 | 100 | 157 | 122 | 113 | 106 | 116 |
| Operating income | −40 | −29 | −129 | −1,561 | −168 | −321 | −270 | −149 |
| Net interest income | −3 | −3 | −10 | −11 | −16 | −22 | −55 | −61 |
| Provision for credit losses | — | — | — | — | — | 0 | 3 | — |
| Income before tax | −42 | −31 | −146 | −1,560 | −184 | −306 | −321 | −227 |
| Income tax | 0 | 0 | 0 | 2 | 3 | 4 | 2 | −11 |
| Net income | −42 | −31 | −146 | −270 | −58 | −136 | −148 | −98 |
| Diluted EPS | — | — | — | −$650.00 | −$63.00 | −$54.06 | −$45.26 | −$21.48 |
| Diluted shares (average) | — | — | — | — | 3m | 3m | 3m | 5m |
| EBITDA | −39 | −28 | −127 | −1,474 | −81 | −235 | −186 | −64 |
| Quarter | 2024 Q3Sept 2024 | 2024 Q4Dec 2024 | 2025 Q1Mar 2025 | 2025 Q2Jun 2025 | 2025 Q3Sept 2025 | 2025 Q4Dec 2025 | 2026 Q1Mar 2026 | 2026 Q2Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 362 | 371 | 373 | 356 | 345 | 385 | 386 | 386 |
| Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — |
| General and administrative | 27 | 31 | 25 | 23 | 22 | 36 | 26 | 32 |
| Operating income | −107 | −139 | −38 | −34 | −44 | −154 | 8 | 41 |
| Net interest income | −6 | −7 | −9 | −10 | −21 | −16 | −17 | −8 |
| Income before tax | −106 | −124 | −43 | −42 | −69 | −167 | −8 | 17 |
| Income tax | −4 | 5 | 1 | 2 | 0 | −1 | −11 | 1 |
| Net income | −47 | −59 | −20 | −20 | −32 | −76 | 1 | 7 |
| Diluted EPS | −$15.70 | −$21.89 | −$6.28 | −$6.23 | −$9.67 | −$23.08 | $0.32 | −$0.63 |
| EBITDA | −85 | −117 | −17 | −13 | −23 | −133 | 29 | 62 |
Compare with peers
- Addus Homecare Corp income statement
- Healthequity, Inc. income statement
- Progyny, Inc. income statement
- Guardant Health, Inc. income statement
- Pennant Group, Inc. income statement
Head to head: ADUS vs PIIIHQY vs PIIIPGNY vs PIII
More: Health Care Services stocks compared, Health Care sector, rankings of US companies